Portfolio company
NAUT
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a proteomic analysis platform to measure proteins for researchers, drug developers and diagnostic organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Palamedrix
This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.
Portal Biotech
The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
Constellate Proteomics
This company develops single-molecule protein analysis platforms for biopharmaceutical drug developers to monitor antibody quality and rank cell lines during production.
DropCode
This company develops a droplet-microfluidics platform and DNA barcoding to provide protein analysis data for biotechnology and pharmaceutical organisations.
Range Bio
This company develops protein quantification tools for researchers and clinicians to improve diagnostic medicine and accelerate drug development.
